Pituitary neuroendocrine tumors (PitNETs) constitute, together with other tumors of the sellar
region, 15-25% of intracranial neoplasms. In 2017, the World Health Organization proposed …

A classification of pituitary adenomas basing on detailed structural and
immunohistochemical studies is accepted world-wide and is mandatory for each pathologist …

Aggressive pituitary tumors lie between pituitary adenomas and carcinomas, displaying a
particular behavior, with invasion, resistance to conventional therapy and early recurrence …

Pituitary tumours, the most frequent intracranial tumour, are historically considered benign.
However, various pieces of clinical evidence and recent advances in pathological and …

Pituitary adenomas are common tumors arising in adenohypophysial cells or their
precursors. For improving control of the disease an early diagnosis is important. Initially …

The classification of adeno-pituitary tumor was deeply revised over the last 20 years, in
order to better describe the variable and complex biological and clinical behavior of these …

Objective: From a recently instituted web-based pituitary tumour registry at Sultan Qaboos
University Hospital, Oman, this study explores the results of comprehensive clinical …

Somatotroph (GH) adenomas/PitNETs typically arise from adenohypophysis and are
biochemically active, leading to acromegaly and gigantism. More rarely, they present with …

Abstract The European Society of Endocrinology (ESE) survey reported on the largest cohort
of 125 aggressive pituitary tumours (APT) and 40 pituitary carcinomas (PC). Whilst the …

Context Silent pituitary adenomas are anterior pituitary tumors with hormone synthesis but
without signs or symptoms of hormone hypersecretion. They have been increasingly …